3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
10
Lymphoma
8
Lymphoma, Non-Hodgkin
7
Lymphoma, Large B-Cell, Diffuse
7
Lymphoma, Follicular
6
Recurrence
4
Neoplasms
3
Lymphoma, Mantle-Cell
3
Lymphoma, B-Cell, Marginal Zone
3
Leukemia, B-Cell
2
Burkitt Lymphoma
2
Neoplasm, Residual
1
Mature B-Cell Malignancies
1
Lymphoma, B-Cell
1
Lymphatic Diseases
1
Leukemia, Hairy Cell
1
Heart Failure
1
Dendritic Cell Sarcoma, Interdigitating
1
Cytokine Release Syndrome
1
Interventions
Carboplatin
3
fludarabine
2
Radiotherapy, Intensity-Modulated
2
Pemetrexed
2
Cyclophosphamide
2
Cisplatin
2
Cerebral Decortication
2
pembrolizumab
1
fludarabine phosphate
1
Platinum
1
Fluorodeoxyglucose F18
1
Blood Component Removal
1
Bevacizumab
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma
×
obinutuzumab
×
30 days
×
Clear all
No trials found.